Elsevier chosen to publish ISN's Kidney International and Kidney International Supplements journals

Elsevier, a world-leading provider of scientific, technical and medical information products and services, and the International Society of Nephrology (ISN), the global medical society devoted to advancing kidney care worldwide, announced today that Elsevier will publish ISN's flagship journals, Kidney International and Kidney International Supplements, as of January 1, 2016.

Now in its 43rd year of publication, Kidney International is one of the most highly cited journals in nephrology and widely regarded as one of the world's premier journals on the development and consequences of kidney disease. It is led by Editor-in-Chief Detlef Schlondorff, MD, Mount Sinai Medical Center, New York, NY, and supported by a world-class editorial board. The journal publishes peer-reviewed original research in both basic science and clinical medicine covering renal physiology, biochemistry, pathology, immunology, morphology, complications of chronic kidney disease, treatment by dialysis and kidney transplantation, and more. Kidney International Supplements is a peer-reviewed companion journal to Kidney International publishing sponsored, topical content of interest to the nephrology community.

David Harris, ISN's Publications Committee Chair, said, "I am delighted that ISN managed to find a great publisher in Elsevier. Considering the big changes happening in the field of medical publishing, it is very reassuring that Kidney International is such an attractive journal to Elsevier. Even more important for our not-for-profit society is the fact that royalties from Kidney International contribute a large part of our philanthropic activities' budget."

"Elsevier is delighted and honored to be partnering with ISN in the publication of their highly respected journals," commented Elsevier's Anne Kitson, Executive Vice President, Health and Medical Sciences Journals. "We are excited to have the opportunity to work with ISN and the editorial team to ensure continued success of both journals and to explore new avenues for collaboration."

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
UVA researchers discover how blood pressure medications affect kidneys